Flumetasone

DERMATOLOGICALS

Key facts

Flumetasone is an ofm drug catalogued in DrugCentral. Recorded indications include Atopic dermatitis, Contact dermatitis, Discoid lupus erythematosus and Eruption of skin.

• Approval status: ofm.
• Indications: Atopic dermatitis, Contact dermatitis, Discoid lupus erythematosus, Eruption of skin and Granuloma annulare and others.
• ATC code: D07AB03 (Corticosteroids, moderately potent (group II)).
• Molecular formula: C22H28F2O5; molecular weight 410.46 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (12)

• Atopic dermatitis
• Contact dermatitis
• Discoid lupus erythematosus
• Eruption of skin
• Granuloma annulare
• Lichen simplex chronicus
• Plaque psoriasis
• Primary cutaneous T-cell lymphoma
• Pruritus ani
• Pruritus of genital organs
• Scalp psoriasis
• Seborrheic dermatitis

Contraindications (4)

• Atrophoderma
• Hypopituitarism
• Skin striae
• Telangiectasia disorder

Regulatory approvals (1)

Date	Agency	Marketed as	Applicant	Orphan
—	FDA	—	—

ATC classification

ATC code	Therapeutic hierarchy
D07AB03	DERMATOLOGICALS › CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS › CORTICOSTEROIDS, PLAIN › Corticosteroids, moderately potent (group II)
D07BB01	DERMATOLOGICALS › CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS › CORTICOSTEROIDS, COMBINATIONS WITH ANTISEPTICS › Corticosteroids, moderately potent, combinations with antiseptics
D07CB05	DERMATOLOGICALS › CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS › CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS › Corticosteroids, moderately potent, combinations with antibiotics
D07XB01	DERMATOLOGICALS › CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS › CORTICOSTEROIDS, OTHER COMBINATIONS › Corticosteroids, moderately potent, other combinations
S02CA02	SENSORY ORGANS › OTOLOGICALS › CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION › Corticosteroids and antiinfectives in combination

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA term	LLR
Product label confusion	561.9
Grip strength decreased	531.1
Blepharospasm	507.2
Coeliac disease	488.3
Nail disorder	484.3
Breast cancer stage III	466.0
Finger deformity	460.9
Adverse reaction	454.0
Back injury	433.7
Bursitis	426.6
Facet joint syndrome	401.0
Taste disorder	370.7

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Flumetasone is on its molecule page.

• Molecular formula: C₂₂H₂₈F₂O₅
• Molecular weight: 410.46 g/mol
• CAS number: 2135-17-3
• InChIKey: WXURHACBFYSXBI-GQKYHHCASA-N
• PubChem CID: 16490

C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Flumetasone used for?

DrugCentral lists the following indications for Flumetasone: Atopic dermatitis, Contact dermatitis, Discoid lupus erythematosus, Eruption of skin, Granuloma annulare, Lichen simplex chronicus, Plaque psoriasis and Primary cutaneous T-cell lymphoma and others.

What is the chemical formula of Flumetasone?

Flumetasone has the molecular formula C22H28F2O5 and a molecular weight of 410.46 g/mol.

Sources

• DrugCentral drug card 4548 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL1201392 — compound record and bioactivity
• PubChem CID 16490 — chemical identifiers
• DrugBank DB00663 — drug record
• FDA UNII LR3CD8SX89 — substance identity
• DailyMed: FDA labels for Flumetasone — current prescribing information (label search)
• FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral

How this page is built: methodology · editorial policy & corrections.